SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking - 2003 -- Ignore unavailable to you. Want to Upgrade?


To: scott_jiminez who wrote (48)1/3/2003 4:32:09 PM
From: RCMac  Read Replies (1) | Respond to of 383
 
I, and anyone else could buy as many shares of UNVC as I'd like for this contest. PERIOD.
In 'reality', perhaps not in a single shot, and perhaps not with the price staying put,


That seem to concede the point -- your contest entry includes all the shares at 4 cents, and you couldn't possibly have bought them for that price. A buying program, let alone an order, for 300,000+ shares would have driven up the price by a wide margin. Hence the unreality of of your UNVC position.

Speaking of unreality, To whit [wit?]: is Amgen a biotech?

Whatever the definition of a biotech, AMGN is an easy case. It develops and markets several therapeutics that are manufactured through biological, and biologically-engineered, means. Yeah, it's a biotech.

That's an easy case. Unlike your medical-device and medical services marketing company.



To: scott_jiminez who wrote (48)1/3/2003 4:52:43 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 383
 
>>To whit: is Amgen a biotech?<<

Taking up your challenge, I will define a biotech company as one that uses cells (mammalian or bacteria) to make medicines.

Amgen, Biogen, Genentech, Serono, Genzyme, Regeneron, Ligand, and many others qualify.

Companies that manufacture bulk pharmaceuticals do not qualify. Sepracor does not qualify for example. UNVC does not qualify for example. Many companies in this biotech forum are not biotech, but share the properties of biopharmaceutical companies: they aim to produce parenteral, oral or topical medicines that treat the causes or symptoms of some disease or affliction. None (that I have seen) are device companies (and few focus on topical medicines for that matter.) Some are services companies, if you include contract manufacturers in this category.